_id
691b11ac3c536f8df2318aa1
Ticker
ALTHX.PA
Name
Theranexus SA
Exchange
PA
Address
60, Avenue Rockefeller, Lyon, France, 69008
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.theranexus.com
Description
THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France.
Last Close
1.98
Volume
45897
Current Price
2.14
Change
2.525252525252516
Last Updated
2025-12-30T12:42:53.834Z
Image
https://logo.clearbit.com/www.theranexus.com
Ipo Date
-
Market Cap
27255498
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
48000
Gross Profit
-48000
Operating Expenses
1103000
Operating Income
-1151000
Interest Expense
-
Pretax Income
-1113000
Net Income
-1072000
Eps
-0.12557767781805035
Dividends Per Share
-
Shares Outstanding
13765403
Income Tax Expense
-41000
EBITDA
-1063000
Operating Margin
-
Total Other Income Expense Net
38000
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
48000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
39
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
2
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
48000
Quarters > 0 > income Statement > gross Profit
-48000
Quarters > 0 > income Statement > operating Expenses
1103000
Quarters > 0 > income Statement > operating Income
-1151000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1113000
Quarters > 0 > income Statement > net Income
-1072000
Quarters > 0 > income Statement > eps
-0.12557767781805035
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8536549
Quarters > 0 > income Statement > income Tax Expense
-41000
Quarters > 0 > income Statement > EBITDA
-1063000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
38000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
48000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.12557767781805035
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
35043
Quarters > 1 > income Statement > cost Of Revenue
683945
Quarters > 1 > income Statement > gross Profit
-648903
Quarters > 1 > income Statement > operating Expenses
551494
Quarters > 1 > income Statement > operating Income
-2371141
Quarters > 1 > income Statement > interest Expense
119577
Quarters > 1 > income Statement > pretax Income
-2343330
Quarters > 1 > income Statement > net Income
-932980
Quarters > 1 > income Statement > eps
-0.10929240844280283
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8536549
Quarters > 1 > income Statement > income Tax Expense
-477370
Quarters > 1 > income Statement > EBITDA
-1175982
Quarters > 1 > income Statement > operating Margin
-6766.375595696715
Quarters > 1 > income Statement > total Other Income Expense Net
27811
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
714313
Quarters > 1 > balance Sheet > short Term Investments
252276
Quarters > 1 > balance Sheet > receivables
582065
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2581624
Quarters > 1 > balance Sheet > property Plant Equipment
17571
Quarters > 1 > balance Sheet > total Assets
3739597
Quarters > 1 > balance Sheet > payables
876146
Quarters > 1 > balance Sheet > short Term Debt
1152358
Quarters > 1 > balance Sheet > long Term Debt
2871240
Quarters > 1 > balance Sheet > total Liabilities
5396510
Quarters > 1 > balance Sheet > equity
-1656913
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-932980
Quarters > 1 > cash Flow > depreciation
24412
Quarters > 1 > cash Flow > change In Working Capital
434092
Quarters > 1 > cash Flow > cash From Operations
-991522
Quarters > 1 > cash Flow > capital Expenditures
446
Quarters > 1 > cash Flow > cash From Investing
87054
Quarters > 1 > cash Flow > cash From Financing
117435
Quarters > 1 > cash Flow > net Change In Cash
298549
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.10929240844280283
Quarters > 1 > ratios > PB
-11.025452066584062
Quarters > 1 > ratios > ROE
56.30832759475
Quarters > 1 > ratios > ROA
-24.948677624888457
Quarters > 1 > ratios > FCF
-991968
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-28.307165482407328
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
2213292
Quarters > 2 > income Statement > cost Of Revenue
1249037
Quarters > 2 > income Statement > gross Profit
964255
Quarters > 2 > income Statement > operating Expenses
1189829
Quarters > 2 > income Statement > operating Income
-225574
Quarters > 2 > income Statement > interest Expense
33286
Quarters > 2 > income Statement > pretax Income
-189903
Quarters > 2 > income Statement > net Income
100803
Quarters > 2 > income Statement > eps
0.01299221366812378
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7758724
Quarters > 2 > income Statement > income Tax Expense
-290707
Quarters > 2 > income Statement > EBITDA
-178175
Quarters > 2 > income Statement > operating Margin
-10.19178671408924
Quarters > 2 > income Statement > total Other Income Expense Net
35671
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
415764
Quarters > 2 > balance Sheet > short Term Investments
1337857
Quarters > 2 > balance Sheet > receivables
40244
Quarters > 2 > balance Sheet > inventories
-1164267
Quarters > 2 > balance Sheet > total Current Assets
3049678
Quarters > 2 > balance Sheet > property Plant Equipment
24843
Quarters > 2 > balance Sheet > total Assets
4263745
Quarters > 2 > balance Sheet > payables
1114199
Quarters > 2 > balance Sheet > short Term Debt
1185079
Quarters > 2 > balance Sheet > long Term Debt
2935700
Quarters > 2 > balance Sheet > total Liabilities
4267194
Quarters > 2 > balance Sheet > equity
-3449
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
100803
Quarters > 2 > cash Flow > depreciation
47400
Quarters > 2 > cash Flow > change In Working Capital
-274107
Quarters > 2 > cash Flow > cash From Operations
-2312951
Quarters > 2 > cash Flow > capital Expenditures
2176
Quarters > 2 > cash Flow > cash From Investing
-10012
Quarters > 2 > cash Flow > cash From Financing
-828150
Quarters > 2 > cash Flow > net Change In Cash
-783102
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
0.01299221366812378
Quarters > 2 > ratios > PB
-4814.0531632357215
Quarters > 2 > ratios > ROE
-2922.6732386198896
Quarters > 2 > ratios > ROA
2.3641892280143395
Quarters > 2 > ratios > FCF
-2315127
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0460106483916265
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
74669
Quarters > 3 > income Statement > cost Of Revenue
2667748
Quarters > 3 > income Statement > gross Profit
-2593079
Quarters > 3 > income Statement > operating Expenses
1142398
Quarters > 3 > income Statement > operating Income
-3777072
Quarters > 3 > income Statement > interest Expense
38945
Quarters > 3 > income Statement > pretax Income
-3767592
Quarters > 3 > income Statement > net Income
-3181732
Quarters > 3 > income Statement > eps
-0.41392319711962205
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
7686769
Quarters > 3 > income Statement > income Tax Expense
-585701
Quarters > 3 > income Statement > EBITDA
-3640600
Quarters > 3 > income Statement > operating Margin
-5058.4204957880775
Quarters > 3 > income Statement > total Other Income Expense Net
9688
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
1198866
Quarters > 3 > balance Sheet > short Term Investments
3705868
Quarters > 3 > balance Sheet > receivables
4753
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5967145
Quarters > 3 > balance Sheet > property Plant Equipment
30098
Quarters > 3 > balance Sheet > total Assets
7237737
Quarters > 3 > balance Sheet > payables
1126098
Quarters > 3 > balance Sheet > short Term Debt
1182303
Quarters > 3 > balance Sheet > long Term Debt
3643021
Quarters > 3 > balance Sheet > total Liabilities
5016189
Quarters > 3 > balance Sheet > equity
2221548
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-3181684
Quarters > 3 > cash Flow > depreciation
88025
Quarters > 3 > cash Flow > change In Working Capital
595149
Quarters > 3 > cash Flow > cash From Operations
-2460700
Quarters > 3 > cash Flow > capital Expenditures
2995
Quarters > 3 > cash Flow > cash From Investing
-61322
Quarters > 3 > cash Flow > cash From Financing
2630556
Quarters > 3 > cash Flow > net Change In Cash
402666
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.41392319711962205
Quarters > 3 > ratios > PB
7.404605104188611
Quarters > 3 > ratios > ROE
-143.22139337074867
Quarters > 3 > ratios > ROA
-43.960315220075
Quarters > 3 > ratios > FCF
-2463695
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-32.99488408844366
Quarters > 3 > health Score
13
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2283377
Annuals > 0 > income Statement > cost Of Revenue
2616927
Annuals > 0 > income Statement > gross Profit
-333550
Annuals > 0 > income Statement > operating Expenses
2292815
Annuals > 0 > income Statement > operating Income
-4810269
Annuals > 0 > income Statement > interest Expense
152863
Annuals > 0 > income Statement > pretax Income
-2533233
Annuals > 0 > income Statement > net Income
-1765156
Annuals > 0 > income Statement > eps
-0.20677629800988667
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
8536549
Annuals > 0 > income Statement > income Tax Expense
768077
Annuals > 0 > income Statement > EBITDA
-2530140
Annuals > 0 > income Statement > operating Margin
-210.66468655854905
Annuals > 0 > income Statement > total Other Income Expense Net
2277036
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
714313
Annuals > 0 > balance Sheet > short Term Investments
252276
Annuals > 0 > balance Sheet > receivables
582065
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2581624
Annuals > 0 > balance Sheet > property Plant Equipment
17571
Annuals > 0 > balance Sheet > total Assets
3739597
Annuals > 0 > balance Sheet > payables
876146
Annuals > 0 > balance Sheet > short Term Debt
1152358
Annuals > 0 > balance Sheet > long Term Debt
1718881
Annuals > 0 > balance Sheet > total Liabilities
5396510
Annuals > 0 > balance Sheet > equity
-1656913
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-1765156
Annuals > 0 > cash Flow > depreciation
96224
Annuals > 0 > cash Flow > change In Working Capital
594076
Annuals > 0 > cash Flow > cash From Operations
-3368771
Annuals > 0 > cash Flow > capital Expenditures
32723
Annuals > 0 > cash Flow > cash From Investing
77042
Annuals > 0 > cash Flow > cash From Financing
-646417
Annuals > 0 > cash Flow > net Change In Cash
-3938145
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.20677629800988667
Annuals > 0 > ratios > PB
-10.81936885038623
Annuals > 0 > ratios > ROE
106.53281131839753
Annuals > 0 > ratios > ROA
-47.20177067208044
Annuals > 0 > ratios > FCF
-3401494
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.489676912748092
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
296331
Annuals > 1 > income Statement > cost Of Revenue
4935021
Annuals > 1 > income Statement > gross Profit
-4638690
Annuals > 1 > income Statement > operating Expenses
3004987
Annuals > 1 > income Statement > operating Income
-7643677
Annuals > 1 > income Statement > interest Expense
83965
Annuals > 1 > income Statement > pretax Income
-7629793
Annuals > 1 > income Statement > net Income
-6827952
Annuals > 1 > income Statement > eps
-0.8800354285060276
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7758724
Annuals > 1 > income Statement > income Tax Expense
-801841
Annuals > 1 > income Statement > EBITDA
-7387231
Annuals > 1 > income Statement > operating Margin
-2579.4388707222665
Annuals > 1 > income Statement > total Other Income Expense Net
13884
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
1198866
Annuals > 1 > balance Sheet > short Term Investments
3705868
Annuals > 1 > balance Sheet > receivables
4753
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5967145
Annuals > 1 > balance Sheet > property Plant Equipment
30098
Annuals > 1 > balance Sheet > total Assets
7237737
Annuals > 1 > balance Sheet > payables
1126098
Annuals > 1 > balance Sheet > short Term Debt
1182303
Annuals > 1 > balance Sheet > long Term Debt
3643021
Annuals > 1 > balance Sheet > total Liabilities
5016189
Annuals > 1 > balance Sheet > equity
2221548
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-6827952
Annuals > 1 > cash Flow > depreciation
256263
Annuals > 1 > cash Flow > change In Working Capital
255292
Annuals > 1 > cash Flow > cash From Operations
-6358214
Annuals > 1 > cash Flow > capital Expenditures
43608
Annuals > 1 > cash Flow > cash From Investing
-61107
Annuals > 1 > cash Flow > cash From Financing
2216442
Annuals > 1 > cash Flow > net Change In Cash
-4202878
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.8800354285060276
Annuals > 1 > ratios > PB
7.334219382160548
Annuals > 1 > ratios > ROE
-307.35109032080334
Annuals > 1 > ratios > ROA
-94.33821648949112
Annuals > 1 > ratios > FCF
-6401822
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-21.603618926133276
Annuals > 1 > health Score
12
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
414898
Annuals > 2 > income Statement > cost Of Revenue
332000
Annuals > 2 > income Statement > gross Profit
82898
Annuals > 2 > income Statement > operating Expenses
5925000
Annuals > 2 > income Statement > operating Income
-6257000
Annuals > 2 > income Statement > interest Expense
158000
Annuals > 2 > income Statement > pretax Income
-7186000
Annuals > 2 > income Statement > net Income
-6567000
Annuals > 2 > income Statement > eps
-1.228346120889684
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
5346213
Annuals > 2 > income Statement > income Tax Expense
-619000
Annuals > 2 > income Statement > EBITDA
-5925139
Annuals > 2 > income Statement > operating Margin
-1508.0815043697487
Annuals > 2 > income Statement > total Other Income Expense Net
-929833
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
2104819
Annuals > 2 > balance Sheet > short Term Investments
7002795
Annuals > 2 > balance Sheet > receivables
18441
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
10528667
Annuals > 2 > balance Sheet > property Plant Equipment
204331
Annuals > 2 > balance Sheet > total Assets
12053746
Annuals > 2 > balance Sheet > payables
855158
Annuals > 2 > balance Sheet > short Term Debt
1283818
Annuals > 2 > balance Sheet > long Term Debt
4888955
Annuals > 2 > balance Sheet > total Liabilities
6325764
Annuals > 2 > balance Sheet > equity
5727982
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-6567000
Annuals > 2 > cash Flow > depreciation
332000
Annuals > 2 > cash Flow > change In Working Capital
1068071
Annuals > 2 > cash Flow > cash From Operations
-5373594
Annuals > 2 > cash Flow > capital Expenditures
41219
Annuals > 2 > cash Flow > cash From Investing
323533
Annuals > 2 > cash Flow > cash From Financing
1631462
Annuals > 2 > cash Flow > net Change In Cash
3587918
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.228346120889684
Annuals > 2 > ratios > PB
1.9600353667312502
Annuals > 2 > ratios > ROE
-114.64770664432953
Annuals > 2 > ratios > ROA
-54.48098873163579
Annuals > 2 > ratios > FCF
-5414813
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-13.050949872016737
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
602
Annuals > 3 > income Statement > cost Of Revenue
8822572
Annuals > 3 > income Statement > gross Profit
-8821970
Annuals > 3 > income Statement > operating Expenses
690239
Annuals > 3 > income Statement > operating Income
-9512810
Annuals > 3 > income Statement > interest Expense
33201
Annuals > 3 > income Statement > pretax Income
-9908836
Annuals > 3 > income Statement > net Income
-8150414
Annuals > 3 > income Statement > eps
-1.6553725891941549
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4923613
Annuals > 3 > income Statement > income Tax Expense
-1758422
Annuals > 3 > income Statement > EBITDA
-8671925
Annuals > 3 > income Statement > operating Margin
-1580200.996677741
Annuals > 3 > income Statement > total Other Income Expense Net
-396026
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
5519695
Annuals > 3 > balance Sheet > short Term Investments
7006517
Annuals > 3 > balance Sheet > receivables
2073805
Annuals > 3 > balance Sheet > inventories
415320
Annuals > 3 > balance Sheet > total Current Assets
15015336
Annuals > 3 > balance Sheet > property Plant Equipment
419119
Annuals > 3 > balance Sheet > total Assets
16889929
Annuals > 3 > balance Sheet > payables
918432
Annuals > 3 > balance Sheet > short Term Debt
1137577
Annuals > 3 > balance Sheet > long Term Debt
5326943
Annuals > 3 > balance Sheet > total Liabilities
6708225
Annuals > 3 > balance Sheet > equity
8722683
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-8150414
Annuals > 3 > cash Flow > depreciation
1203709
Annuals > 3 > cash Flow > change In Working Capital
409103
Annuals > 3 > cash Flow > cash From Operations
-6249547
Annuals > 3 > cash Flow > capital Expenditures
150618
Annuals > 3 > cash Flow > cash From Investing
-150618
Annuals > 3 > cash Flow > cash From Financing
7713990
Annuals > 3 > cash Flow > net Change In Cash
-3192068
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-1.6553725891941549
Annuals > 3 > ratios > PB
1.185367770444025
Annuals > 3 > ratios > ROE
-93.43930072891563
Annuals > 3 > ratios > ROA
-48.25605838840412
Annuals > 3 > ratios > FCF
-6400165
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-10631.503322259136
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.12557767781805035
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-23.02
Risk > final Score
-62
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
17
Prev Profitabilities > 2
0
Prev Risks > 0
-49
Prev Risks > 1
3
Prev Risks > 2
-370
Prev Liquidities > 0
82
Prev Liquidities > 1
83
Prev Liquidities > 2
100
Updated At
2026-01-22T21:22:11.380Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-24
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.11
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.11
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-29
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.2
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.2
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-26
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-12
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-1.31
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-1.31
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-07-12
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.65
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-04-25
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-1.62
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-1.62
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-30
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.82
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.82
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-07
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.42
Earnings History > 7 > eps Estimate
-0.94
Earnings History > 7 > eps Difference
0.52
Earnings History > 7 > surprise Percent
55.3191
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-12-11
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.79
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.79
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-04-09
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.68
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.68
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-11-26
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.89
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.89
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-04-17
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.71
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.71
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-09-30
Earnings History > 12 > report Date
2018-10-01
Earnings History > 12 > date
2018-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-1.22
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-1.22
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-04-26
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.83
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.83
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-10-11
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.42
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.42
Earnings History > 14 > surprise Percent
-
THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Theranexus SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.11
EPS Estimate
0
EPS Difference
-0.11
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.